These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8848368)

  • 1. Clinical benefit of dual chamber pacing in hypertrophic cardiomyopathy: a case report.
    Teixeira JM; Greenway PS; Staedtler C; Bareis R
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):120-3. PubMed ID: 8848368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study.
    Nishimura RA; Hayes DL; Ilstrup DM; Holmes DR; Tajik AJ
    J Am Coll Cardiol; 1996 Feb; 27(2):421-30. PubMed ID: 8557915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of biventricular pacing on left ventricular outflow tract pressure gradient in a patient with hypertrophic cardiomyopathy and normal interventricular conduction.
    Komsuoglu B; Vural A; Agacdiken A; Ural D
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):207-9. PubMed ID: 16533259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy.
    Honda T; Shono H; Koyama J; Tsuchiya T; Hayashi M; Hirayama T; Uesugi H; Honda T
    Circ J; 2005 May; 69(5):536-42. PubMed ID: 15849439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
    Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L; Cannon RO; Tripodi D; Panza JA
    Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy.
    Rishi F; Hulse JE; Auld DO; McRae G; Kaltman J; Kanter K; Williams W; Campbell RM
    J Am Coll Cardiol; 1997 Mar; 29(4):734-40. PubMed ID: 9091517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients.
    Berruezo A; Linhart M; Auricchio A; Zamorano JL; Santamaria P; Borràs R; Burgos F; Brugada J
    J Interv Card Electrophysiol; 2018 Mar; 51(2):117-124. PubMed ID: 29397524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
    Park MH; Gilligan DM; Bernardo NL; Topaz O
    Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
    Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ
    J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function.
    Betocchi S; Losi MA; Piscione F; Boccalatte M; Pace L; Golino P; Perrone-Filardi P; Briguori C; Franculli F; Pappone C; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Mar; 77(7):498-502. PubMed ID: 8629591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000.
    Erwin JP; Nishimura RA; Lloyd MA; Tajik AJ
    Mayo Clin Proc; 2000 Feb; 75(2):173-80. PubMed ID: 10683657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy.
    McAreavey D; Fananapazir L
    Am J Cardiol; 1992 Sep; 70(6):651-6. PubMed ID: 1510015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
    Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
    Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pacemaker therapy in a pediatric patient with hypertrophic obstructive cardiomyopathy and rapid intrinsic atrioventricular conduction.
    Mann C; Antretter H; Hammerer I
    Pediatr Cardiol; 1999; 20(3):229-31. PubMed ID: 10089254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for anti-ischemic effect of dual-chamber pacing in patients with the obstructive form of hypertrophic cardiomyopathy.
    Mohri M; Ichiki T; Kuga T; Takeshita A
    Jpn Heart J; 2003 Jul; 44(4):587-92. PubMed ID: 12906041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC (Pacing in Cardiomyopathy) Study Group].
    Meisel E; Rauwolf T; Burghardt M; Kappenberger L
    Herz; 2000 Jun; 25(4):461-6. PubMed ID: 10948782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age.
    Topilski I; Sherez J; Keren G; Copperman I
    Am J Cardiol; 2006 Jun; 97(12):1769-75. PubMed ID: 16765132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.